Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-14

FDA Approved: OXALIPLATIN — Original Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved Mylan Institutional LLC's original application for generic oxaliplatin, a platinum-based chemotherapy agent. Oxaliplatin is used to treat colorecta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)

Snippet

ORIG AP for OXALIPLATIN (OXALIPLATIN)